VPAResearch: Market Research Reports

VPA Research is one of the global pharmaceutical companies specialized in analysis of clinical trials. We provide leading insights into global Pharma products, pipeline research, companies and drugs markets.

Publications found: 64,029

Sort by:

Toxoplasmosis R&D Pipeline Analysis Report, Q4 2020

US$ 1,529.00

Toxoplasmosis Pipeline Overview The Q4 Toxoplasmosis pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under development...

October 2020 30 pages

Tularaemia R&D Pipeline Analysis Report, Q4 2020

US$ 1,529.00

Tularaemia Pipeline Overview The Q4 Tularaemia pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under development for T...

October 2020 45 pages

Typhoid Fever R&D Pipeline Analysis Report, Q4 2020

US$ 1,529.00

Typhoid Fever Pipeline Overview The Q4 Typhoid Fever pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under development...

October 2020 61 pages

Vancomycin-Resistant Enterococcus faecium Infections R&D Pipeline Analysis Report, Q4 2020

US$ 1,529.00

Vancomycin-Resistant Enterococcus faecium Infections Pipeline Overview The Q4 Vancomycin-Resistant Enterococcus faecium Infections pipeline report is part of the VPA 110 Infectious Disease pipeline se...

October 2020 103 pages

Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections R&D Pipeline Analysis Report, Q4 2020

US$ 1,529.00

Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections Pipeline Overview The Q4 Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections pipeline report is part of the VPA 110 Infectious Dis...

October 2020 61 pages

Ventilator Associated Pneumonia (VAP) R&D Pipeline Analysis Report, Q4 2020

US$ 1,529.00

Ventilator Associated Pneumonia (VAP) Pipeline Overview The Q4 Ventilator Associated Pneumonia (VAP) pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review d...

October 2020 126 pages

Warts R&D Pipeline Analysis Report, Q4 2020

US$ 1,529.00

Warts Pipeline Overview The Q4 Warts pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under development for Warts, prov...

October 2020 108 pages

West Nile Virus Infections R&D Pipeline Analysis Report, Q4 2020

US$ 1,529.00

West Nile Virus Infections Pipeline Overview The Q4 West Nile Virus Infections pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline...

October 2020 63 pages

Western Equine Encephalitis R&D Pipeline Analysis Report, Q4 2020

US$ 1,529.00

Western Equine Encephalitis Pipeline Overview The Q4 Western Equine Encephalitis pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipelin...

October 2020 30 pages

Yellow Fever R&D Pipeline Analysis Report, Q4 2020

US$ 1,529.00

Yellow Fever Pipeline Overview The Q4 Yellow Fever pipeline report is part of the VPA 110 Infectious Disease pipeline service. This quarterly review describes the pipeline of drugs under development f...

October 2020 63 pages

2020 COVID-19 Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

US$ 2,159.00

Report Description The September updated COVID-19 clinical trials report presents a comprehensive 1800 page analysis on all clinical trials across 96 countries worldwide. The report provides phase wis...

September 2020 1800 pages

COVID-19 Therapy and Vaccine Drug Pipeline Market Report- September 2020 Update

US$ 2,609.00

The September 2020 updated COVID-19 report identifies 440 companies investing in therapy and vaccination products. Around 24 companies have advanced their products into Phase 3 and around 15 companies...

September 2020 512 pages

COVID-19 Therapy and Vaccine Drug Pipeline and Clinical Trials Report- September 2020 Update

US$ 3,825.00

COVID-19 Pipeline Analysis The September 2020 updated COVID-19 report identifies 440 companies investing in therapy and vaccination products. Around 24 companies have advanced their products into Phas...

September 2020 2300 pages

Acne Vulgaris pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Acne Vulgaris PIPELINE HIGHLIGHTS Acne Vulgaris is one of the widely researched conditions during 2020 with 42 companies actively focusing on realizing pipeline’s potential. Development of Acne V...

July 2020 210 pages

Acromegaly pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Acromegaly PIPELINE HIGHLIGHTS Acromegaly is one of the widely researched conditions during 2020 with 22 companies actively focusing on realizing pipeline’s potential. Development of Acromegaly m...

July 2020 96 pages

Actinic Keratosis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Actinic Keratosis PIPELINE HIGHLIGHTS Actinic Keratosis is one of the widely researched conditions during 2020 with 10 companies actively focusing on realizing pipeline’s potential. Development o...

July 2020 59 pages

Alcoholic Hepatitis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Alcoholic Hepatitis PIPELINE HIGHLIGHTS Alcoholic Hepatitis is one of the widely researched conditions during 2020 with 14 companies actively focusing on realizing pipeline’s potential. Developme...

July 2020 72 pages

Alopecia pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Alopecia PIPELINE HIGHLIGHTS Alopecia is one of the widely researched conditions during 2020 with 40 companies actively focusing on realizing pipeline’s potential. Development of Alopecia medicin...

July 2020 200 pages

Anemia in Chronic Kidney Disease pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Anemia in Chronic Kidney Disease PIPELINE HIGHLIGHTS Anemia in Chronic Kidney Disease is one of the widely researched conditions during 2020 with 25 companies actively focusing on realizing pipel...

July 2020 124 pages

Angina (Angina Pectoris) pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Angina (Angina Pectoris) PIPELINE HIGHLIGHTS Angina (Angina Pectoris) is one of the widely researched conditions during 2020 with 9 companies actively focusing on realizing pipeline’s potential....

July 2020 53 pages

Aplastic Anemia pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Aplastic Anemia PIPELINE HIGHLIGHTS Aplastic Anemia is one of the widely researched conditions during 2020 with 15 companies actively focusing on realizing pipeline’s potential. Development of Ap...

July 2020 84 pages

Arrhythmias pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Arrhythmias PIPELINE HIGHLIGHTS Arrhythmias is one of the widely researched conditions during 2020 with 15 companies actively focusing on realizing pipeline’s potential. Development of Arrhythmia...

July 2020 72 pages

Arterial Thrombosis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Arterial Thrombosis PIPELINE HIGHLIGHTS Arterial Thrombosis is one of the widely researched conditions during 2020 with 8 companies actively focusing on realizing pipeline’s potential. Developmen...

July 2020 48 pages

Atrial Fibrillation pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Atrial Fibrillation PIPELINE HIGHLIGHTS Atrial Fibrillation is one of the widely researched conditions during 2020 with 23 companies actively focusing on realizing pipeline’s potential. Developme...

July 2020 121 pages

Atypical Hemolytic Uremic Syndrome pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Atypical Hemolytic Uremic Syndrome PIPELINE HIGHLIGHTS Atypical Hemolytic Uremic Syndrome is one of the widely researched conditions during 2020 with 9 companies actively focusing on realizing pi...

July 2020 63 pages

Axillary Hyperhidrosis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Axillary Hyperhidrosis PIPELINE HIGHLIGHTS Axillary Hyperhidrosis is one of the widely researched conditions during 2020 with 7 companies actively focusing on realizing pipeline’s potential. Deve...

July 2020 51 pages

Behcet Disease pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Behcet Disease PIPELINE HIGHLIGHTS Behcet Disease is one of the widely researched conditions during 2020 with 8 companies actively focusing on realizing pipeline’s potential. Development of Behce...

July 2020 47 pages

Bullous Pemphigoid pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Bullous Pemphigoid PIPELINE HIGHLIGHTS Bullous Pemphigoid is one of the widely researched conditions during 2020 with 10 companies actively focusing on realizing pipeline’s potential. Development...

July 2020 59 pages

Burns pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Burns PIPELINE HIGHLIGHTS Burns is one of the widely researched conditions during 2020 with 32 companies actively focusing on realizing pipeline’s potential. Development of Burns medicines is ide...

July 2020 146 pages

Celiac Disease pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Celiac Disease PIPELINE HIGHLIGHTS Celiac Disease is one of the widely researched conditions during 2020 with 19 companies actively focusing on realizing pipeline’s potential. Development of Celi...

July 2020 89 pages

Colitis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Colitis PIPELINE HIGHLIGHTS Colitis is one of the widely researched conditions during 2020 with 27 companies actively focusing on realizing pipeline’s potential. Development of Colitis medicines...

July 2020 112 pages

Constipation pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Constipation PIPELINE HIGHLIGHTS Constipation is one of the widely researched conditions during 2020 with 16 companies actively focusing on realizing pipeline’s potential. Development of Constipa...

July 2020 82 pages

Contact Dermatitis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Contact Dermatitis PIPELINE HIGHLIGHTS Contact Dermatitis is one of the widely researched conditions during 2020 with 5 companies actively focusing on realizing pipeline’s potential. Development...

July 2020 40 pages

Contrast Induced Nephropathy pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Contrast Induced Nephropathy PIPELINE HIGHLIGHTS Contrast Induced Nephropathy is one of the widely researched conditions during 2020 with 3 companies actively focusing on realizing pipeline’s pot...

July 2020 35 pages

Coronary Artery Disease (CAD) pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Coronary Artery Disease (CAD) PIPELINE HIGHLIGHTS Coronary Artery Disease (CAD) is one of the widely researched conditions during 2020 with 39 companies actively focusing on realizing pipeline’s...

July 2020 176 pages

Critical Limb Ischemia pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Critical Limb Ischemia PIPELINE HIGHLIGHTS Critical Limb Ischemia is one of the widely researched conditions during 2020 with 27 companies actively focusing on realizing pipeline’s potential. Dev...

July 2020 121 pages

Deep Vein Thrombosis (DVT) pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Deep Vein Thrombosis (DVT) PIPELINE HIGHLIGHTS Deep Vein Thrombosis (DVT) is one of the widely researched conditions during 2020 with 6 companies actively focusing on realizing pipeline’s potenti...

July 2020 46 pages

Diabetic Gastroparesis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Diabetic Gastroparesis PIPELINE HIGHLIGHTS Diabetic Gastroparesis is one of the widely researched conditions during 2020 with 10 companies actively focusing on realizing pipeline’s potential. Dev...

July 2020 62 pages

Diarrhea pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Diarrhea PIPELINE HIGHLIGHTS Diarrhea is one of the widely researched conditions during 2020 with 29 companies actively focusing on realizing pipeline’s potential. Development of Diarrhea medicin...

July 2020 145 pages

Dilated Cardiomyopathy pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Dilated Cardiomyopathy PIPELINE HIGHLIGHTS Dilated Cardiomyopathy is one of the widely researched conditions during 2020 with 9 companies actively focusing on realizing pipeline’s potential. Deve...

July 2020 54 pages

Down Syndrome pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Down Syndrome PIPELINE HIGHLIGHTS Down Syndrome is one of the widely researched conditions during 2020 with 13 companies actively focusing on realizing pipeline’s potential. Development of Down S...

July 2020 75 pages

End Stage Kidney Disease (ESRD) pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 End Stage Kidney Disease (ESRD) PIPELINE HIGHLIGHTS End Stage Kidney Disease (ESRD) is one of the widely researched conditions during 2020 with 8 companies actively focusing on realizing pipeline...

July 2020 52 pages

Enterocolitis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Enterocolitis PIPELINE HIGHLIGHTS Enterocolitis is one of the widely researched conditions during 2020 with 11 companies actively focusing on realizing pipeline’s potential. Development of Entero...

July 2020 60 pages

Eosinophilic Esophagitis (EoE) pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Eosinophilic Esophagitis (EoE) PIPELINE HIGHLIGHTS Eosinophilic Esophagitis (EoE) is one of the widely researched conditions during 2020 with 18 companies actively focusing on realizing pipeline’...

July 2020 79 pages

Epidermolysis Bullosa pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Epidermolysis Bullosa PIPELINE HIGHLIGHTS Epidermolysis Bullosa is one of the widely researched conditions during 2020 with 33 companies actively focusing on realizing pipeline’s potential. Devel...

July 2020 156 pages

Fanconi Anemia pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Fanconi Anemia PIPELINE HIGHLIGHTS Fanconi Anemia is one of the widely researched conditions during 2020 with 6 companies actively focusing on realizing pipeline’s potential. Development of Fanco...

July 2020 50 pages

Functional Dyspepsia (Non Ulcer Dyspepsia) pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Functional Dyspepsia (Non Ulcer Dyspepsia) PIPELINE HIGHLIGHTS Functional Dyspepsia (Non Ulcer Dyspepsia) is one of the widely researched conditions during 2020 with 4 companies actively focusing...

July 2020 42 pages

Gastric Ulcers pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Gastric Ulcers PIPELINE HIGHLIGHTS Gastric Ulcers is one of the widely researched conditions during 2020 with 6 companies actively focusing on realizing pipeline’s potential. Development of Gastr...

July 2020 42 pages

Gastritis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Gastritis PIPELINE HIGHLIGHTS Gastritis is one of the widely researched conditions during 2020 with 8 companies actively focusing on realizing pipeline’s potential. Development of Gastritis medic...

July 2020 58 pages

Gastroenteritis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Gastroenteritis PIPELINE HIGHLIGHTS Gastroenteritis is one of the widely researched conditions during 2020 with 8 companies actively focusing on realizing pipeline’s potential. Development of Gas...

July 2020 58 pages

Filters

Clear all